Patricia A. Marken

935 total citations
27 papers, 656 citations indexed

About

Patricia A. Marken is a scholar working on Psychiatry and Mental health, Geriatrics and Gerontology and Pharmacology. According to data from OpenAlex, Patricia A. Marken has authored 27 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 6 papers in Geriatrics and Gerontology and 4 papers in Pharmacology. Recurrent topics in Patricia A. Marken's work include Schizophrenia research and treatment (10 papers), Electroconvulsive Therapy Studies (6 papers) and Bipolar Disorder and Treatment (6 papers). Patricia A. Marken is often cited by papers focused on Schizophrenia research and treatment (10 papers), Electroconvulsive Therapy Studies (6 papers) and Bipolar Disorder and Treatment (6 papers). Patricia A. Marken collaborates with scholars based in United States and United Kingdom. Patricia A. Marken's co-authors include Radwan F. Haykal, Joseph N. Fisher, Robert D. Schremmer, Christopher Kennedy, Katharine V. Smith, Mark Bunker, Steven C. Stoner, Ronald W. Pies, Roger W. Sommi and Barbara G. Wells and has published in prestigious journals such as Atherosclerosis, Journal of Clinical Psychopharmacology and The Journal of Clinical Pharmacology.

In The Last Decade

Patricia A. Marken

26 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patricia A. Marken United States 13 273 101 88 84 76 27 656
Jagoda Pasic United States 13 325 1.2× 103 1.0× 61 0.7× 77 0.9× 169 2.2× 23 999
Jolene R. Bostwick United States 14 337 1.2× 92 0.9× 72 0.8× 151 1.8× 69 0.9× 62 866
Eileen E. Ming United States 10 234 0.9× 134 1.3× 167 1.9× 187 2.2× 89 1.2× 13 1.3k
Michael W. Kelly United States 16 185 0.7× 35 0.3× 45 0.5× 120 1.4× 88 1.2× 30 672
Nicholas Dunn United Kingdom 11 277 1.0× 65 0.6× 97 1.1× 265 3.2× 56 0.7× 20 782
Pierre M. Bet Netherlands 19 174 0.6× 66 0.7× 93 1.1× 122 1.5× 45 0.6× 65 1.0k
Helen Fung Kum Chiu Hong Kong 20 240 0.9× 73 0.7× 241 2.7× 63 0.8× 87 1.1× 29 1.1k
Richard J. Milne New Zealand 12 87 0.3× 75 0.7× 82 0.9× 97 1.2× 41 0.5× 16 926
Martin Grønbech Jørgensen Denmark 20 222 0.8× 68 0.7× 215 2.4× 100 1.2× 51 0.7× 61 1.0k
Dean G. Haxby United States 14 139 0.5× 112 1.1× 166 1.9× 90 1.1× 61 0.8× 29 769

Countries citing papers authored by Patricia A. Marken

Since Specialization
Citations

This map shows the geographic impact of Patricia A. Marken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia A. Marken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia A. Marken more than expected).

Fields of papers citing papers by Patricia A. Marken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia A. Marken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia A. Marken. The network helps show where Patricia A. Marken may publish in the future.

Co-authorship network of co-authors of Patricia A. Marken

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia A. Marken. A scholar is included among the top collaborators of Patricia A. Marken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia A. Marken. Patricia A. Marken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hardinger, Karen L., et al.. (2015). Enrollment management strategies in the professional pharmacy program: A focus on progression and retention. Currents in Pharmacy Teaching and Learning. 7(2). 199–206. 9 indexed citations
2.
3.
4.
Marken, Patricia A.. (2011). Personalized Medicine: Are We Preparing Our Students for the Knowledge Revolution?. American Journal of Pharmaceutical Education. 75(3). 48–48. 5 indexed citations
5.
Marken, Patricia A., et al.. (2010). Human Simulators and Standardized Patients to Teach Difficult Conversations to Interprofessional Health Care Teams. American Journal of Pharmaceutical Education. 74(7). 120–120. 94 indexed citations
6.
Goggin, Kathy, Starlyn M. Hawes, Elizabeth R. Duval, et al.. (2010). A Motivational Interviewing Course for Pharmacy Students. American Journal of Pharmaceutical Education. 74(4). 70–70. 38 indexed citations
7.
Stoner, Steven C., et al.. (2006). Historical Review of Carbamazepine for the Treatment of Bipolar Disorder. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(1). 68–88. 14 indexed citations
8.
Stoner, Steven C., et al.. (2004). Extended‐Release Divalproex Sodium for Mood Stabilization. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(9). 1147–1153. 5 indexed citations
9.
Stoner, Steven C., et al.. (2003). A Program to Convert Patients from Trade‐Name to Generic Clozapine. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(6). 806–810. 10 indexed citations
10.
Marken, Patricia A., et al.. (2000). Atypical antipsychotic agents: A critical review. American Journal of Health-System Pharmacy. 57(3). 238–255. 146 indexed citations
11.
Marken, Patricia A., et al.. (2000). Clozapine-Associated Extrapyramidal Reaction. Annals of Pharmacotherapy. 34(5). 615–618. 5 indexed citations
12.
Bunker, Mark, et al.. (1997). Attenuation of Antipsychotic-Induced Hyperprolactinemia with Clozapine. Journal of Child and Adolescent Psychopharmacology. 7(1). 65–69. 21 indexed citations
13.
Marken, Patricia A., et al.. (1994). Preliminary Comparison of Predictive and Empiric Lithium Dosing: Impact on Patient Outcome. Annals of Pharmacotherapy. 28(10). 1148–1152. 7 indexed citations
14.
Marken, Patricia A., et al.. (1994). An Atypical Course of Neuroleptic Malignant Syndrome. The Journal of Clinical Pharmacology. 34(4). 325–334. 7 indexed citations
15.
Marken, Patricia A. & Robert Evans. (1993). Survey of Psychopharmacy Curricula and Faculty at Schools of Pharmacy. American Journal of Pharmaceutical Education. 57(4). 330–332. 4 indexed citations
16.
Marken, Patricia A., et al.. (1993). Criteria for use of lithium in adult inpatients and outpatients.. PubMed. 12(8). 617–21. 1 indexed citations
17.
Lacombe, S., et al.. (1991). Pharmacologic Treatment of Cocaine Abuse. DICP. 25(7-8). 818–823. 6 indexed citations
18.
Wells, Barbara G., et al.. (1989). Characterizing Anticholinergic Abuse in Community Mental Health. Journal of Clinical Psychopharmacology. 9(6). 431???435–431???435. 21 indexed citations
19.
Marken, Patricia A., Barbara G. Wells, & Candace Brown. (1989). Treatment of Psychosis in Pregnancy. DICP. 23(7-8). 598–600. 1 indexed citations
20.
Marken, Patricia A., et al.. (1989). Effects of magnesium oxide on the lipid profile of healthy volunteers. Atherosclerosis. 77(1). 37–42. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026